Impact of interferon-alpha therapy on liver fibrosis progression in patients with HBeAg-negative chronic hepatitis B
Author:
Publisher
Wiley
Subject
Virology,Infectious Diseases,Hepatology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2893.2005.00582.x/fullpdf
Reference25 articles.
1. Mechanisms and therapy of hepatic fibrosis: Report of the AASLD single topic basic research conference
2. Histological grading and staging of chronic hepatitis
3. Natural history of liver fibrosis progression in patients with chronic hepatitis C
4. Impact of Interferon Alfa-2b and Ribavirin on Progression of Liver Fibrosis in Patients With Chronic Hepatitis C
5. Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C
Cited by 30 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Comparison of fibrosis regression of entecavir alone or combined with pegylated interferon alpha2a in patients with chronic hepatitis B;Hepatology International;2021-03-07
2. Chronic Hepatitis B Virus Infection: Interferon Therapy and Long-Term Outcomes;Hepatitis B Virus and Liver Disease;2021
3. The Role of Elastography in HBV: Assessing Liver Fibrosis;Elastography of the Liver and Beyond;2021
4. Regression of Fibrosis Stage With Treatment Reduces Long-Term Risk of Liver Cancer in Patients With Hemochromatosis Caused by Mutation in HFE;Clinical Gastroenterology and Hepatology;2020-07
5. Regression of liver fibrosis: evidence and challenges;Chinese Medical Journal;2020-06-19
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3